Clinical Trial Update: A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC) [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update describes an early-phase (Phase 1) study of HB-202 and HB-201 in HPV16-positive head and neck squamous cell carcinoma; the trial is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• HB-201
• HB-202

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: HPV16+ Squamous Cell Carcinoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING